145 related articles for article (PubMed ID: 17876153)
21. S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials.
Zhong S; Qie S; Yang L; Yan Q; Ge L; Wang Z
Medicine (Baltimore); 2017 Jul; 96(30):e7611. PubMed ID: 28746215
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
[No Abstract] [Full Text] [Related]
23. Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer.
Suzuki S; Ozaki Y; Saida S; Kaji S; Koike N; Harada N; Hayashi T; Suzuki M
Hepatogastroenterology; 2013 Jun; 60(124):916-20. PubMed ID: 23478143
[TBL] [Abstract][Full Text] [Related]
24. [A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy].
Masuda T; Kuwahara A
Gan To Kagaku Ryoho; 2008 May; 35(5):833-5. PubMed ID: 18487924
[TBL] [Abstract][Full Text] [Related]
25. [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Kubo H; Kijima T; Kitahara M; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2010 Jan; 37(1):147-50. PubMed ID: 20087051
[TBL] [Abstract][Full Text] [Related]
26. Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.
Aoyama T; Katayama Y; Murakawa M; Shiozawa M; Morimoto M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Hepatogastroenterology; 2015; 62(137):200-6. PubMed ID: 25911897
[TBL] [Abstract][Full Text] [Related]
27. [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Ishikawa T; Mizuno K; Watanabe K; Baba Y; Oota H; Yoshida T; Kamimura T
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1555-8. PubMed ID: 15508450
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report].
Yoshino T; Fukutomi A; Boku N
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1521-3. PubMed ID: 17033251
[TBL] [Abstract][Full Text] [Related]
29. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
[TBL] [Abstract][Full Text] [Related]
30. [Recent important insights into treatment of pancreatic cancer].
Abe N; Sugiyama M; Atomi Y
Gan To Kagaku Ryoho; 2005 May; 32(5):617-23. PubMed ID: 15918560
[TBL] [Abstract][Full Text] [Related]
31. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine as second-line chemotherapy].
Kawamoto K; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Niwano M; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1131-4. PubMed ID: 17637556
[TBL] [Abstract][Full Text] [Related]
32. [Gemcitabine infusion via splenic artery for advanced pancreatic cancer].
Baba H; Endo M; Arii S
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1689-92. PubMed ID: 14619495
[TBL] [Abstract][Full Text] [Related]
33. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
Fukui H; Kou C; Matsumoto T; Matsumoto M
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
[TBL] [Abstract][Full Text] [Related]
34. [Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report].
Tanaka S; Fujii M; Goubaru M; Ohta T; Ogata M; Makino Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1485-7. PubMed ID: 16227755
[TBL] [Abstract][Full Text] [Related]
35. [Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases].
Fukui H; Kou C; Fujioka M
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1727-31. PubMed ID: 23152029
[TBL] [Abstract][Full Text] [Related]
36. [A case of unresectable advanced pancreatic cancer treated by S-1 with concurrent radiotherapy].
Ishiguro A; Munakata M; Shitara K; Suzuki K; Takahata T; Itoh J; Aoki M; Sakata Y; Munakata A
Gan To Kagaku Ryoho; 2007 Jun; 34(6):937-40. PubMed ID: 17565261
[TBL] [Abstract][Full Text] [Related]
37. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
[TBL] [Abstract][Full Text] [Related]
38. [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
Fukada I; Ikeda H; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Kawamoto K; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1733-6. PubMed ID: 19838037
[TBL] [Abstract][Full Text] [Related]
39. [A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy].
Murata A; Kimura K; Amano R; Hirata K; Nagahara H; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Otani H; Maeda K; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1865-7. PubMed ID: 24393948
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Uesaka K; Boku N; Fukutomi A; Okamura Y; Konishi M; Matsumoto I; Kaneoka Y; Shimizu Y; Nakamori S; Sakamoto H; Morinaga S; Kainuma O; Imai K; Sata N; Hishinuma S; Ojima H; Yamaguchi R; Hirano S; Sudo T; Ohashi Y;
Lancet; 2016 Jul; 388(10041):248-57. PubMed ID: 27265347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
